Consider the following medical report that includes the patient's historical health records. Use it to predict the disease that the patient is high likely exposed to. 

 Medical Report: allergies: penicillins attending: chief complaint: melena major surgical or invasive procedure: upper endoscopy history of present illness: hpi: pt is 50 yo f with h/o stage iia clear cell cancer of the ovary, s/p surgery and six cycles of carboplatin and taxol completed in with no known disease recurrence, who was found to have a hct of 16.9 today. pt had seen her pcp several weeks ago, and reportedly had an abdominal ct showing enlarged "groin lymph nodes." pt then had an abdominal mri, which reportedly showed gallstones (unclear if lymph nodes were still considered to be pathologic by mri). pt says she has had fatigue for the past 5 days, as well as black, tarry stools x 5 days. she says she gets sob after walking 1000ft. no cp, n/v, f/c, hematemesis, hemoptysis, or brbpr. + night sweats x several days as well as lightheadedness x several days. she has used motrin, asa, and alleve prn x 3 days for a headache. pt saw her oncologist today to discuss her recent radiographic findings, and also c/o fatigue at that time. cbc showed hct 16.9, and she was told to come to the ed. . in the , pt had ngl which showed coffee-ground material, but reportedly then became negative after 800cc ns. she had guaiac + black stool on rectal exam. she recieved 1l ns, 1 u prbc, and protonix 40mg iv. the gi service was consulted. pt is now being transferred to the for further management. . . . : pt arrived to the in hemodynamically stable condition. large bore iv's were placed, ppi started. she was seen by the gi service and underwent egd on , which revealed 2 ulcers at the rim of her hiatal hernia. a single ulcer was actively oozing at its edge, and was treated with cautery. pt received 3u prbc in total, with increase in hct from 16 to 28. on , pt was without further hematemesis. she had 2 bm which were formed, dark, but without red blood. she denies abdominal pain, n/v. she was tolerating clears without difficulty. h. pylori serologies were ordered. pt was continued on sucralfate qid. she was transferred to the medical floor on . past medical history: - stage iia clear cell cancer of the ovary: found during surgery for endometriosis and fibroids, s/p tah-bso and six cycles of carboplatin and taxol completed in with no known disease recurrence - pyloric stenosis status post vagotomy and pyeloplasty/pyloric sphincter in - ? h/o afib - htn - asthma - h/o r bell's palsy social history: married. no children. no smoking, etoh, or ivdu. . family history: father had 2 mi's (first at age 63). mother had mi in her 60's. brother had mi at age 57. physical exam: vitals: t 97.1 bp 136/60 hr 91 rr 16 o2 99% 2l gen: nad, lying in bed, pale heent: perrl. neck: supple cardio: rrr, nl s1s2, 2/6 sem @ lusb resp: ctab. no wheeze. abd: obese, soft, nt, +bs. healed midline vertical scar. ext: no c/c/e neuro: a&ox3 pertinent results: 11:15pm wbc-10.7 rbc-2.85*# hgb-7.8*# hct-23.2*# mcv-81* mch-27.3 mchc-33.6 rdw-17.3* 11:15pm plt count-348 03:50pm glucose-129* urea n-17 creat-0.8 sodium-140 potassium-3.6 chloride-105 total co2-22 anion gap-17 03:50pm iron-22* 03:50pm caltibc-312 ferritin-2.6* trf-240 03:50pm wbc-9.6 rbc-1.88* hgb-4.8* hct-15.3* mcv-82 mch-25.6* mchc-31.4 rdw-19.0* 03:50pm neuts-77.1* lymphs-18.7 monos-2.5 eos-1.6 basos-0.2 03:50pm hypochrom-3+ anisocyt-2+ microcyt-2+ 03:50pm plt count-403 03:50pm pt-12.4 ptt-19.2* inr(pt)-1.1 10:55am alt(sgpt)-17 ast(sgot)-22 alk phos-97 10:55am ca125-14 10:55am wbc-10.7 rbc-2.11*# hgb-5.4*# hct-16.9*# mcv-80*# mch-25.5*# mchc-31.8 rdw-19.0* 10:55am plt count-473* 10:55am gran ct-7970 . cxr: lungs clear. heart size normal. no pleural effusion. small hiatus hernia present. nasogastric tube ends in the upper stomach. no pneumothorax or appreciable pleural effusion. . brief hospital course: # ugib/anemia - s/p successful cautery of two ulcers at edge of hiatal hernia via egd on , felt likely due to excess nsaid usage, adised to avoid nsaids. - continue ppi (change to po today), treated in house with sucralfate. - hct remained stable 24h post egd -h. pylori negative . # ovarian ca - no known dx recurrence, f/u osh imaging studies for ? of increased intrabdominal lymphadenopathy. discussed with oncologist, f/u with dr. . . . # htn - holding verapamil in setting of gib, bp remained stable, restarted on d/c. . . # asthma - continue home meds. . . # fen - - tolerating reg diet . medications on admission: verapamil 80mg singulair qd ventolin prn flovent advil, motrin, asa prn discharge medications: 1. montelukast 10 mg tablet sig: one (1) tablet po daily (daily). 2. fluticasone 110 mcg/actuation aerosol sig: two (2) puff inhalation (2 times a day). 3. pantoprazole 40 mg tablet, delayed release (e.c.) sig: one (1) tablet, delayed release (e.c.) po q12h (every 12 hours). disp:*60 tablet, delayed release (e.c.)(s)* refills:*2* 4. ventolin 90 mcg/actuation aerosol sig: two (2) puff inhalation every four (4) hours as needed for shortness of breath or wheezing. 5. verapamil 80 mg tablet sig: one (1) tablet po twice a day. discharge disposition: home discharge diagnosis: upper gi bleed discharge condition: stable discharge instructions: please continue your medications as listed below. please make sure you avoid taking any over the counter pain medications other than tylenol without checking with your doctor. please also avoid alcohol. call your doctor if you experience continuing black stool beyond the next day, or lightheadedness, shortness of breath, or fatigue. followup instructions: 1. please follow up with your pcp in the next 1-2 weeks. 2. provider: , md phone: date/time: 9:00 3. provider: , hematology/oncology-cc9 date/time: 9:00 procedure: endoscopic control of gastric or duodenal bleeding diagnoses: unspecified essential hypertension acute posthemorrhagic anemia asthma, unspecified type, unspecified diaphragmatic hernia without mention of obstruction or gangrene chronic or unspecified gastric ulcer with hemorrhage, without mention of obstruction unspecified analgesic and antipyretic causing adverse effects in therapeutic use 

Answer: The patient is high likely exposed to